首页> 外国专利> Replaced imidazole y neuropeptide y5 receptor y5 antagonists

Replaced imidazole y neuropeptide y5 receptor y5 antagonists

机译:替代咪唑γ神经肽y5受体y5拮抗剂

摘要

"IMMEDAZOLE Y NEUROPEPTIDE Y RECEPTOR Y5 ANTAGONISTS". Compounds of formula (I) or a pharmaceutically acceptable salt, solvate or N-oxide thereof, wherein X is = CH- or = N-; Y is H, halogen, trialoalkyl, alkyl, alkenyl, cycloalkyl, cycloalkyl, SH, -S-alkyl or -CN. R is alkyl, -CF-3-, cycloalkyl, heterocycloalkyl, heterocycloalkylalkyl, heteroarylalkyl or adamantyl or optionally substituted phenyl, phenoxyalkyl, phenylthioalkyl, pyridyl, thienyl, thiazolyl, pyrazinyl, 1,2,5,6-tetrahydropyridine or formula (A). wherein R 10 and R 11 are hydrogen, alkyl or together form a cycloalkyl, are disclosed, as well as pharmaceutical compositions and methods of using said compounds in the treatment of eating disorders and diabetes.
机译:“咪唑Y神经肽Y受体Y5拮抗剂”。式(I)化合物或其药学上可接受的盐,溶剂化物或N-氧化物,其中X为= CH-或= N-; Y为H,卤素,三烷基,烷基,烯基,环烷基,环烷基,SH,-S-烷基或-CN。 R为烷基,-CF 3-,环烷基,杂环烷基,杂环烷基烷基,杂芳基烷基或金刚烷基或任选取代的苯基,苯氧基烷基,苯硫基烷基,吡啶基,噻吩基,噻唑基,吡嗪基,1,2,5,6-四氢吡啶或式(A) 。公开了其中R 10和R 11是氢,烷基或一起形成环烷基的药物,以及药物组合物和使用所述化合物治疗饮食失调和糖尿病的方法。

著录项

  • 公开/公告号BR0017025A

    专利类型

  • 公开/公告日2003-01-07

    原文格式PDF

  • 申请/专利权人 SCHERING CORPORATION;

    申请/专利号BR20000017025

  • 申请日2000-12-14

  • 分类号C07D233/54;C07D413/10;C07D401/10;C07D401/04;C07D401/12;C07D403/12;C07D401/06;A61K31/415;

  • 国家 BR

  • 入库时间 2022-08-22 00:03:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号